BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen LP, Zhao J, Du Y, Han YF, Su T, Zhang HW, Cao GW. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma. World J Virol 2012; 1(6): 174-183 [PMID: 24175223 DOI: 10.5501/wjv.v1.i6.174]
URL: https://www.wjgnet.com/2220-3249/full/v1/i6/174.htm
Number Citing Articles
1
Vahdat Poortahmasebi, Reza Malekzadeh, Ghodratollah Montazeri, Ehsan Fakhari, Mehdi Norouzi, Azam Khamseh, Masoud Mahmoodi Karkhaneh, Ahmad Tavakoli, Seyed Mohammad Jazayeri. Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical FeaturesJundishapur Journal of Microbiology 2015; 8(9) doi: 10.5812/jjm.20262
2
Sofia Vitor, Rui Tato Marinho, José Gíria, José Velosa. An observational study of the direct costs related to hospital admissions, mortality and premature death associated with liver disease in PortugalBMC Research Notes 2016; 9(1) doi: 10.1186/s13104-016-1879-8
3
Yutaka Furutani, Mariko Toguchi, Yumi Shiozaki-Sato, Xian-Yang Qin, Etsuko Ebisui, Shoko Higuchi, Masayuki Sudoh, Harukazu Suzuki, Nobuaki Takahashi, Koichi Watashi, Takaji Wakita, Hideaki Kakeya, Soichi Kojima, Kyun-Hwan Kim. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genesPLOS ONE 2019; 14(6): e0216139 doi: 10.1371/journal.pone.0216139
4
Jian Sun, Huiguo Ding, Guofeng Chen, Guiqiang Wang, Lai Wei, Jiming Zhang, Qing Xie, Mobin Wan, Hong Tang, Shijun Chen, Zhiliang Gao, Yuming Wang, Dazhi Zhang, Wenxiang Huang, Jifang Sheng, Qin Ning, Dongliang Yang, Jian Lu, Chen Pan, Yuxiu Yang, Jue Wang, Chuanzhen Sun, Qixin Wang, Jinlin Hou. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0981-5
5
Senko Tsukuda, Koichi Watashi, Masashi Iwamoto, Ryosuke Suzuki, Hideki Aizaki, Maiko Okada, Masaya Sugiyama, Soichi Kojima, Yasuhito Tanaka, Masashi Mizokami, Jisu Li, Shuping Tong, Takaji Wakita. Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) ExpressionJournal of Biological Chemistry 2015; 290(9): 5673 doi: 10.1074/jbc.M114.602540
6
Wei Luo, Junxia Wang, Dengfeng Xu, Huili Bai, Yangli Zhang, Yuhong Zhang, Xiaosong Li. Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV in�vitro and in�vivoInternational Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3396
7
Thomas H. King, Charles B. Kemmler, Zhimin Guo, Derrick Mann, Yingnian Lu, Claire Coeshott, Adam J. Gehring, Antonio Bertoletti, Zi Z. Ho, William Delaney, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Shikha Shrivastava, Yu-Jin L. Lee, Shyamasundaran Kottilil, Donald Bellgrau, Timothy Rodell, David Apelian, Kim J. Hasenkrug. A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral ClearancePLoS ONE 2014; 9(7): e101904 doi: 10.1371/journal.pone.0101904
8
Wenbin Liu, Guangwen Cao. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach [Working Title]2021;  doi: 10.5772/intechopen.99838
9
Yan Du, Yu-Wei Zhang, Rui Pu, Xue Han, Jian-Ping Hu, Hong-Wei Zhang, Hong-Yang Wang, Guang-Wen Cao. Phosphatase and Tensin Homologue Genetic Polymorphisms and their Interactions with Viral Mutations on the Risk of Hepatocellular CarcinomaChinese Medical Journal 2015; 128(8): 1005 doi: 10.4103/0366-6999.155057
10
Yun Wang, Xiaogang Xiang, Liwen Chen, Zhujun Cao, Rebecca Bao, Huijuan Zhou, Weiliang Tang, Jie Lu, Lanyi Lin, Qing Xie, Shisan Bao, Hui Wang. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancyOncotarget 2016; 7(36): 58553 doi: 10.18632/oncotarget.10155
11
Grace C Lovett, Tin Nguyen, David M Iser, Jacinta A Holmes, Robert Chen, Barbara Demediuk, Gideon Shaw, Sally J Bell, Paul V Desmond, Alexander J Thompson. Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experienceWorld Journal of Hepatology 2017; 9(1): 48-56 doi: 10.4254/wjh.v9.i1.48
12
Mara Cirone. Cancer cells dysregulate PI3K/AKT/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesvirusesCritical Reviews in Biochemistry and Molecular Biology 2021; 56(5): 500 doi: 10.1080/10409238.2021.1934811
13
Min Zhang, Dexin Wang, Haidong Liu, Hui Li. Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resectionInfectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0191-8
14
Jianhui Qu, Zujiang Yu, Qin Li, Yongping Chen, Dedong Xiang, Lin Tan, Chunliang Lei, Wenlin Bai, Hongyan Li, Qinghua Shang, Liang Chen, Xiaoyu Hu, Wei Lu, Zhiqin Li, Da Chen, Xiaodong Wang, Changjiang Zhang, Guangming Xiao, Xun Qi, Jing Chen, Li Zhou, Guofeng Chen, Yonggang Li, Zhen Zeng, Guanghua Rong, Zheng Dong, Yan Chen, Min Lou, Chunping Wang, Yinying Lu, Cuihong Zhang, Yongping Yang. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trialTrials 2014; 15(1) doi: 10.1186/1745-6215-15-438
15
Yuan Zhuang, Hong Ding, Yue Zhang, Huichuan Sun, Chen Xu, Wenping Wang. Two-dimensional Shear-Wave Elastography Performance in the Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis B: Comparison with Serum Fibrosis IndexesRadiology 2017; 283(3): 873 doi: 10.1148/radiol.2016160131
16
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjectsWorld Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
17
Enze Jiang, Anna Junjie Shangguan, Shuangshuang Chen, Lin Tang, Shuang Zhao, Zhenghong Yu. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinomaCancer Letters 2016; 379(2): 262 doi: 10.1016/j.canlet.2015.07.016
18
Gabriele Ricco, Daniela Cavallone, Chiara Cosma, Gian Paolo Caviglia, Filippo Oliveri, Alessandra Biasiolo, Maria Lorena Abate, Mario Plebani, Antonina Smedile, Ferruccio Bonino, Patrizia Pontisso, Maurizia Rossana Brunetto. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkersCancer Biomarkers 2018; 21(3): 603 doi: 10.3233/CBM-170551
19
Baihai Jiao, Xuezhen Shi, Yanzhao Chen, Haiyan Ye, Min Yao, Wenxu Hong, Shilin Li, Xiaoqiong Duan, Yujia Li, Yancui Wang, Limin Chen. Insulin receptor substrate-4 interacts with ubiquitin-specific protease 18 to activate the Jak/STAT signaling pathwayOncotarget 2017; 8(62): 105923 doi: 10.18632/oncotarget.22510
20
Naveen Ganjoo, Thomas D. Schiano. Disease Recurrence After Liver Transplantation2016; : 165 doi: 10.1007/978-1-4939-2947-4_12
21
Shaoyou Qin, Jiangbin Wang, Changyu Zhou, Yan Xu, Yonggui Zhang, Xu Wang, Song Wang. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infectionMedicine 2019; 98(38): e17275 doi: 10.1097/MD.0000000000017275